http://www.enanta.com
Enanta Pharmaceuticals, Inc. Company Intro
Industry
Healthcare
Enanta Pharmaceuticals, Inc. Headquaters
500 Arsenal Street
Watertown,02472
United States
Enanta Pharmaceuticals, Inc. Share price
29 Oct 2020 01:34 GMT
$44.34
-0.67 (-1.49 %)
Enanta Pharmaceuticals, Inc. Market cap
$883.373 M
WMC RANKING
2020
Enanta Pharmaceuticals, Inc. # 42
BiotechnologyLatest Enanta Pharmaceuticals, Inc. News
26 Oct 2020
Alexandria Real Estate Equities, Inc. Reports: 3Q20 Net ...
Alexandria Real Estate Equities, Inc. Reports: 3Q20 Net Income per Share ... Atreca Inc. , Enanta Pharmaceuticals, Inc. , Novartis AG , and Pfizer Inc. , are ...
25 Oct 2020
Primary Biliary Cirrhosis Drug Market Growth Prospects, Key Vendors, Future Scenario Forecast By 2026 | UpMarketResearch
CymaBay Therapeutics Inc. Dr. Falk Pharma GmbH. Enanta Pharmaceuticals Inc. GlaxoSmithKline Plc Intercept Pharmaceuticals Inc. Johnson & Johnson
25 Oct 2020
Primary Biliary Cirrhosis Drug Market Growth Prospects, Key Vendors, Future Scenario Forecast By 2026 | UpMarketResearch
CymaBay Therapeutics Inc. Dr. Falk Pharma GmbH. Enanta Pharmaceuticals Inc. GlaxoSmithKline Plc Intercept Pharmaceuticals Inc. Johnson & Johnson
WMC Market Score
WMC Market to Revenue Score
Enanta Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Enanta Pharmaceuticals, Inc. | USD | $150,155 | $165,580 | $2,364 | $883.373M | 42 |
| Alexion Pharmaceuticals, Inc. | USD | $5,536,800 | $2,523,000 | $846,100 | $25.172B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $5,402,685 | $2,634,428 | $2,080,775 | $54.266B | 2 |
| 3SBio Inc. | CNY | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥18.811B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $19.025B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Enanta Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Enanta Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Enanta Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Enanta Pharmaceuticals, Inc. | 2.71 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.35 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.32 | 26 | 0 | 0 | 97.49 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.27 | 7.19 | 100 | 0 | 0 | 90.87 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
